Double PhD Viva Success
Published: 23 May 2019
We are thrilled to announce the success of two of Hanns’s UK students. Grace McMacken and Rachel Thompson defended their PhD work this week and will be awarded PhDs from Newcastle University following submission of minor corrections. Both have attained their PhDs by published work, Grace on “Congenital Myasthenic Syndromes and the Therapeutic Modulation of the Neuromuscular Junction” and Rachel on “Data sharing and integration for omics research in neuromuscular and rare diseases”. You can read some of those publications for Grace here and Rachel here.
Grace McMacken (left) and Rachel Thompson (right) who successfully defended their PhDs work this week
Read next...
Two Research Lab Members Receive CIHR Funding Awards!
We are excited to share that two of our research team members have received competitive funding awards from the Canadian Institutes of Health Research (CIHR)...
Dr. Hanns Lochmüller’s Canada Research Chair Renewed Through 2032
We are pleased to announce that Dr. Hanns Lochmüller’s Tier 1 Canada Research Chair (CRC) in Neuromuscular Genomics and Health has been renewed through the...
Dr. Kiran Polavarapu Appointed Scientist at the CHEO Research Institute
We are delighted to congratulate Dr. Kiran Polavarapu on his appointment as Scientist at the Children’s Hospital of Eastern Ontario Research Institute (CHEO RI). This...
Meet The Lab’s New Clinical Members!
Our research team is growing! We are excited to announce three new research staff who have joined the lab this winter, as well as two...
Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine
We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice
Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...